Experienced in Acquired Tracheomalacia

Dr. Sunil Singhal

General Surgery
University Of Pennsylvania
3400 Civic Center Blvd, 
Philadelphia, PA 
Offers Telehealth
Experienced in Acquired Tracheomalacia
University Of Pennsylvania
3400 Civic Center Blvd, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sunil Singhal is a General Surgeon in Philadelphia, Pennsylvania. Dr. Singhal is rated as an Experienced provider by MediFind in the treatment of Acquired Tracheomalacia. His top areas of expertise are Lung Nodules, Lung Cancer, Mesothelioma, Thymectomy, and Tissue Biopsy.

His clinical research consists of co-authoring 263 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Pennsylvania School Of Medicine
Residency
Johns Hopkins Hospital
Specialties
General Surgery
Licenses
Thoracic Surgery (Cardiothoracic Vascular Surgery) in PA
Board Certifications
Surgery, 2014
Thoracic And Cardiac Surgery, 2009
Fellowships
Hospital of the University of Pennsylvania
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Chester County Hospital
Pennsylvania Hospital
Penn Presbyterian Medical Center
University Medical Center Of Princeton At Plainsboro
Languages Spoken
English
Gender
Male
Awards
Recognized annually in Philadelphia magazine's Top Docs issue from 2018 through 2025

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

University of Pennsylvania
3400 Civic Center Blvd, Philadelphia, PA 19104

Additional Areas of Focus

Dr. Singhal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Esophageal Cancer
Lung Cancer
Pectus Carinatum
Diaphragmatic Hernia
Pleural Effusion
Mesothelioma
Pectus Excavatum

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer
Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 11, 2025
Intervention Type: Biological
Study Drug: AdV-tk (Aglatimagene Besadenovec)+Valacyclovir
Study Phase: Phase 1
A Phase 2, Single-Dose, Open-Label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies, in Patients Undergoing Routine Surgery
A Phase 2, Single-Dose, Open-Label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies, in Patients Undergoing Routine Surgery
Enrollment Status: Completed
Publish Date: November 08, 2024
Intervention Type: Drug, Procedure
Study Phase: Phase 2
A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Enrollment Status: Completed
Publish Date: March 24, 2023
Intervention Type: Drug, Procedure, Device
Study Phase: Phase 2
A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Enrollment Status: Completed
Publish Date: March 23, 2023
Intervention Type: Drug, Device
Study Drug: OTL38
Study Phase: Phase 3
Intraoperative Imaging of Pulmonary Nodules by OTL38
Intraoperative Imaging of Pulmonary Nodules by OTL38
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Drug: OTL38
Study Phase: Phase 1
Optional Sub-study to Intraoperative Imaging With ICG Registry
Optional Sub-study to Intraoperative Imaging With ICG Registry
Enrollment Status: Completed
Publish Date: June 24, 2021
Intervention Type: Other
Intraoperative Imaging With ICG Registry
Intraoperative Imaging With ICG Registry
Enrollment Status: Completed
Publish Date: June 24, 2021
Intervention Type: Other
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Optional Sub-Study I: ICG Optional Sub-Study II: OTL38
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Optional Sub-Study I: ICG Optional Sub-Study II: OTL38
Enrollment Status: Completed
Publish Date: June 18, 2021
Intervention Type: Drug
A Phase 0/1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subject Undergoing Breast Cancer Surgery
A Phase 0/1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subject Undergoing Breast Cancer Surgery
Enrollment Status: Completed
Publish Date: January 28, 2021
Intervention Type: Drug
Study Phase: Early Phase 1
A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma
A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma
Enrollment Status: Terminated
Publish Date: August 06, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Parathyroidectomy for Primary Hyperparathyroidism.
A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Parathyroidectomy for Primary Hyperparathyroidism.
Enrollment Status: Completed
Publish Date: July 03, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Pilot and Feasibility Study of Intraoperative Imagery of Solid Tumors With Indocyanine Green
A Pilot and Feasibility Study of Intraoperative Imagery of Solid Tumors With Indocyanine Green
Enrollment Status: Completed
Publish Date: March 20, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Pilot & Feasibility Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Minimally Invasive Thoracic Surgery Presenting With Thoracic Nodules
A Pilot & Feasibility Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Minimally Invasive Thoracic Surgery Presenting With Thoracic Nodules
Enrollment Status: Completed
Publish Date: March 20, 2018
Intervention Type: Drug
Study Phase: Phase 1
Intraoperative Imaging of Pulmonary Adenocarcinoma
Intraoperative Imaging of Pulmonary Adenocarcinoma
Enrollment Status: Withdrawn
Publish Date: March 02, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Thoracic Surgery Presenting With Lung Nodules
A Phase 1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Thoracic Surgery Presenting With Lung Nodules
Enrollment Status: Completed
Publish Date: February 05, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 14 Less Clinical Trials

263 Total Publications

Corrigendum to Surgical resection of diffuse pulmonary arteriovenous malformations (PAVMs) [JTCVS Open Volume 23, February 2025, Pages 309-317].
Corrigendum to Surgical resection of diffuse pulmonary arteriovenous malformations (PAVMs) [JTCVS Open Volume 23, February 2025, Pages 309-317].
Journal: JTCVS open
Published: September 09, 2025
Similar Doctors
Advanced in Acquired Tracheomalacia
Dr. Charles Bakhos
General Surgery
Advanced in Acquired Tracheomalacia
Dr. Charles Bakhos
General Surgery

Klein Building

5401 Old York Rd Ste 101, 
Philadelphia, PA 
 (6.7 miles away)
215-456-6178
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Charles Bakhos is a General Surgeon in Philadelphia, Pennsylvania. Dr. Bakhos is rated as a Distinguished provider by MediFind in the treatment of Acquired Tracheomalacia. His top areas of expertise are Tracheobronchomalacia, Pleuropulmonary Blastoma, Lung Nodules, Endoscopy, and Gastric Bypass.

Experienced in Acquired Tracheomalacia
Dr. Saba Aftab
General Surgery
Experienced in Acquired Tracheomalacia
Dr. Saba Aftab
General Surgery

Advocare LLC

406 Lippincott Dr Ste F, 
Marlton, NJ 
 (14.9 miles away)
856-435-9100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Saba Aftab is a General Surgeon in Marlton, New Jersey. Dr. Aftab is rated as an Advanced provider by MediFind in the treatment of Acquired Tracheomalacia. Her top areas of expertise are Laryngeal Nerve Damage, Otitis, Hearing Loss, and Infant Hearing Loss.

Charles Mulligan
Experienced in Acquired Tracheomalacia
Dr. Charles Mulligan
General Surgery
Experienced in Acquired Tracheomalacia
Dr. Charles Mulligan
General Surgery

Office

4701 Ogletown Stanton Rd Ste 2100, 
Newark, DE 
 (33.5 miles away)
302-623-4530
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Charles Mulligan is a General Surgeon in Newark, Delaware. Dr. Mulligan is rated as a Distinguished provider by MediFind in the treatment of Acquired Tracheomalacia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Nodules, Advanced Bronchoscopy, and Gastrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singhal's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 11 Advanced Conditions
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile